Exhibit 99.1 Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results Emeryville, CA, May 14, 2024 - Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics- derived gene editing toolbox, today reported financial results and business updates for the first quarter ended March 31, 2024. "Our continued execution in the first quarter of 2024 furthers our m ...